PEREGRINE PHARMACEUTICALS INC 4
4 · PEREGRINE PHARMACEUTICALS INC · Filed Nov 2, 2015
Insider Transaction Report
Form 4
LYTLE PAUL J
Chief Financial Officer
Transactions
- Other
Common Stock
2015-10-30$0.95/sh+6,158$5,850→ 112,866 total
Footnotes (1)
- [F1]Shares acquired under the issuer's employee stock purchase plan on October 30, 2015.